Steris | STE - Net Income


Steris reported $220.3M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
3M USD 653M 76M Mar/2026
Accuray USD 2.54M 6.49M Dec/2024
Avanos Medical USD 5.1M 6.4M Mar/2026
Baxter International USD -15M 1.11B Mar/2026
Becton, Dickinson and Co. USD -311M 693M Mar/2026
Boston Scientific USD 1.34B 669M Mar/2026
CONMED USD 13.83M 2.91M Mar/2026
Cooper Companies USD -77.9M 208.7M Mar/2026
Dexcom USD 199.5M 67.8M Mar/2026
Ecolab USD 432.6M 131.3M Mar/2026
Edwards Lifesciences USD 380.7M 289.5M Mar/2026
Fortive USD 136.4M 49.3M Mar/2026
Getinge SEK 662M 661M Dec/2024
Globus Medical USD 140.59M 21.63M Dec/2025
Haemonetics USD 44.74M 6.06M Dec/2025
Idexx Laboratories USD 278.45M 30.26M Mar/2026
Inogen USD -5.96M 373K Sep/2024
Insulet USD 91.1M 10.5M Mar/2026
Integra LifeSciences USD -4.62M 2.91M Mar/2026
Intuitive Surgical USD 821.5M 26.7M Mar/2026
J&J USD 5.24B 119M Mar/2026
Olympus JPY 24.82B 10.65B Mar/2026
Orthofix International USD -2.22M 20.57M Dec/2025
Owens Minor USD -56.33M 93.95M Dec/2025
ResMed USD 398.73M 6.14M Mar/2026
Steris USD 220.3M 27.4M Mar/2026
Stryker USD 745M 104M Mar/2026
Tandem Diabetes Care USD -589K 20.58M Dec/2025
Teleflex USD -8.15M 706.18M Mar/2026
Thermo Fisher Scientific USD 1.65B 313M Mar/2026
Zimmer Biomet Holdings USD 238.1M 98.8M Mar/2026